June 3, 2019

Massachusetts Life Sciences Center launches new Seed Fund to catalyze life sciences innovations in underserved regions

New program to provide pre-seed/seed up to-$250K convertible notes to early-stage life sciences companies in Lowell, Worcester, Springfield, Amherst, and Pittsfield

Springfield—Today, the Massachusetts Life Sciences Center (MLSC) announced the launch of its new Seed Fund to catalyze life sciences development and innovations in under-served regions. Through this program, the MLSC and its partners aim to leverage and increase the visibility of regional strengths across the Commonwealth by highlighting opportunities in innovative technologies and individual regional resources. Individual investments will be up to $250,000 in convertible notes with up to $1 million of capital investment available to support life sciences companies in Lowell, Worcester, Springfield, Amherst, and Pittsfield.

Continue reading “Massachusetts Life Sciences Center launches new Seed Fund to catalyze life sciences innovations in underserved regions” »

May 2, 2019

Baker-Polito Administration announces new STEM District initiative to support educational equity in life sciences education and training

Massachusetts Life Sciences Center awards 5 grants for STEM equipment and supplies totaling nearly $1.14 million to school districts of Boston, Brockton, Lawrence, Lowell, and Springfield

Lawrence— Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced nearly $1.14 million in STEM equipment and professional development funding to be distributed across 36 public middle schools and high schools in the five school districts of Boston, Brockton, Lawrence, Lowell, and Springfield. The announcement was made by Lieutenant Governor Karyn Polito during an event at Lawrence High School, where she was joined by Lawrence school officials, representatives from all five awardee districts, and other life sciences and educational stakeholders for the announcement event.

Continue reading “Baker-Polito Administration announces new STEM District initiative to support educational equity in life sciences education and training” »

May 2, 2019

Baker-Polito Administration Announces Job Creation Incentives for 27 Massachusetts Life Sciences Companies

Incentives will create 1,200+ life sciences jobs throughout Massachusetts, including 460+ jobs in manufacturing; 76% of total investment supports expansion outside Greater Boston

WALTHAM— Today, the Baker-Polito Administration announced $20 million in tax incentive awards to 27 life sciences companies. The awards were approved by the Board of Directors of the Massachusetts Life Sciences Center (MLSC), and will create more than 1,200 new jobs across the Commonwealth. The tax incentive awards will support life sciences job growth in 19 different Massachusetts communities, the majority of which are located in or expanding outside of Boston and Cambridge.

Continue reading “Baker-Polito Administration Announces Job Creation Incentives for 27 Massachusetts Life Sciences Companies” »

May 1, 2019

Massachusetts Life Sciences Center Awards Funding to Projects to Enable Biomanufacturing Innovation

Life Sciences Center awards $2.82 million to capital projects that support biomanufacturing innovation; Capital call part of robust, collaborative effort to improve efficiency and effectiveness of delivering therapies to patients

WORCESTER— Today, the Massachusetts Life Sciences Center (MLSC) announced $2.82 million in funding through a new capital program focused on supporting the life sciences ecosystem in Massachusetts by catalyzing biomanufacturing innovation. Housing and Economic Development Secretary Mike Kennealy made the announcement during remarks at the 4th Annual Advanced Biomanufacturing Symposium held at WPI.

Continue reading “Massachusetts Life Sciences Center Awards Funding to Projects to Enable Biomanufacturing Innovation” »

April 29, 2019

Baker-Polito Administration announces $30 million in capital grant funding to support life sciences sector

11 projects to receive funding to sustain the Commonwealth’s competitive edge in advancing human health and connecting communities across Massachusetts to the innovation economy

Waltham – Today, the Baker-Polito Administration and the Massachusetts Life Sciences Center (MLSC) announced $30.95 million in capital grant funding to support the state’s global leadership in the life sciences sector. In total, 11 projects across Massachusetts will receive funding through the MLSC’s Competitive Capital Program to support advances in human health, accelerate innovation in the areas of clinical and translational research, and expand the capacity of life sciences development and job growth across the Commonwealth.

Continue reading “Baker-Polito Administration announces $30 million in capital grant funding to support life sciences sector” »

March 21, 2019

The Data Challenger: Liz O’Day


Elizabeth “Liz” O’Day, Ph.D., founded Olaris Therapeutics in 2014 with an aim to change the game in how we diagnose and treat patients with life threatening diseases. Through innovative technology and customized algorithms, Liz and her team can understand the metabolomic profile of a patient to determine the most effective treatment option. The fundamental goal or mantra for Olaris is “getting the right drug to the right patient” according to Liz.

Liz is one of the inaugural awardees of the MLSC’s Massachusetts Next Generation Initiative (MassNextGen), a five year, more than $2 million commitment to ensure greater gender parity in the next generation of life science entrepreneurs. The MLSC recently closed its second round application call, receiving 30 applications from women-led life sciences companies.

Continue reading “The Data Challenger: Liz O’Day” »

February 28, 2019

Massachusetts Life Sciences Center awards $25,000 grant to National Society of Black Engineers Boston

Funding to support organization’s ongoing efforts in youth, collegiate, and professional development programming

WALTHAM— Today, the Massachusetts Life Sciences Center announced $25,000 in funding for the National Society of Black Engineers (NSBE) Boston Professionals. The funding will support NSBE Boston’s pre-collegiate, collegiate, and professional development initiatives. The NSBE’s mission is to increase the number of culturally responsible black engineers who excel academically, succeed professionally, and positively impact the community.

“Our ecosystem will only be as strong as our commitment to increase the diversity of engineers, scientists, educators and others who contribute to and benefit from the life sciences sector,” said MLSC President and CEO Travis McCready. “No one entity is responsible for the healthy state of the life sciences or any sector within our innovation economy.  I applaud the work of NSBE for their dedication to our collective commitment to creating opportunities at every level of educational and career development for the next generation of black engineers and STEM professionals.”

The National Society of Black Engineers has a bold vision of encouraging students to pursue a career in engineering, with an ultimate goal of increasing the annual number of black engineering bachelor’s degree recipients to 10,000 by 2025. With this worthy mission in mind, NSBE Boston has shaped its programming to inspire the innovators of tomorrow through professional advancement, youth, pre-college, and collegiate initiatives, and cultural and community-focused initiatives.

“All black students should be able to envision themselves as engineers or scientists,” said Ladi Olaoye of NSBE Boston. “Moreover, there is a national imperative for more black engineers to continue our country’s progress in STEM fields. We are grateful for the funding the MLSC is providing to spark and sustain interest in engineering and technology and provide experiences for students and professionals. This will open new doors and opportunities in academic achievement, leadership, and collaboration.”

More than 160 professional members are currently participating in NSBE Boston programming, which includes monthly career networking and professional development opportunities. NSBE Boston programming through STEM outreach events and initiatives, including participation in NSBE Jr. Chapters, have impacted more than 250 students in grades 3-12. At the college level, NSBE Boston actively supports 15 student chapters all over New England. This translates into 500-plus college student members enrolled in some form of STEM programming.

NSBE Boston, founded in 1988 as the “NSBE New England Alumni Extension”, recently celebrated its 30th Anniversary with the inaugural Boston STEM Benefit, to honor the accomplishments of black innovators and change-makers in the Boston area and to recognize the impact of NSBE Boston on more than 2000 local students and professionals over the last 30 years. Visit NSBE Boston to find out more information.

About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an economic development investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world.  Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health.  Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs.  These investments have created thousands of jobs, and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.

###

February 28, 2019

At the Forefront of the North Shore’s Life Sciences Activity


In 1981, a medical device company named Abiomed in Danvers, Massachusetts was at the forefront of designing what would become the modern version of the artificial heart. The company’s drive to save lives led to the very first patient being treated with Abiomed’s implantable artificial heart in 2001.

The company’s mission and vision evolved with the industry’s. Abiomed’s footprint expanded beyond the United States when it acquired a German company, Impella CardioSystems, in 2005. Instead of only focusing on replacing hearts, this acquisition enabled Abiomed to expand its portfolio into technologies that enable a heart attack patient’s heart to rest and recover, so the patient can go home with his or her native heart. Abiomed developed the world’s smallest heart pump and by 2008, the Impella heart pump received its first FDA clearance in the United States.

In 2015, 2016, and 2017, Abiomed was an awardee of the Massachusetts Life Sciences Center’s Tax Incentive Program. The program offers tax incentives to companies engaged in life sciences research and development, commercialization, and manufacturing in Massachusetts in order to expand life sciences-related employment opportunities and promote health-related innovations in the life sciences.

Since 2007, Abiomed has grown threefold from 350 employees to 1,300 worldwide. In Massachusetts, there are roughly 450 employees at the company’s Danvers headquarters and manufacturing facility. The company’s space in Danvers has also grown in recent years with Abiomed doubling its footprint from 60,000 to 120,000 square feet. Ian McLeod, Abiomed’s vice president and corporate controller, relayed that the company’s ability to create 170 jobs in Massachusetts through the MLSC Tax Incentive Program has empowered the company to build a culture that continues to drive success and innovation.

“The benefits of having our headquarters in Massachusetts have been immeasurable,” said Mr. McLeod. “With a strong and committed education and workforce collaboration, Massachusetts’ pipeline of talent is unparalleled.”

Abiomed offers co-op and internship opportunities to students in the state, partnering with colleges and universities throughout the Commonwealth. With the company’s headquarters just twenty miles from Boston, it has developed a young, diverse and well-prepared workforce.

“Having our headquarters in Danvers is ideal,” added Mr. McLeod “In the last two years, we expanded our presence to include a completed innovation center for engineering, manufacturing, and clean room space.”

Abiomed is a well-established pillar in a part of the state that continues to experience a wave of activity in the life sciences and related fields. Commonwealth Diagnostics International in Salem is a fellow MLSC Tax Incentive awardee; biotech and clean-tech startup incubator North Shore InnoVentures is located in Beverly; PCI Synthesis,the largest small molecule CDMA in New England, is headquartered in Newburyport; and this past October, the ribbon was cut on the Gloucester Marine Genomics Institute’s new facility to advance marine biotechnology research and expand the regional economy.

Last year alone, the MLSC awarded more than $19 million in tax incentive awards to 23 companies that committed to creating 1,189 net new jobs in the Commonwealth by the end of the 2018 calendar year.  Roughly half of those awards went to support companies who are hiring and expanding outside of Greater Boston. Learn more about the program.

February 11, 2019

Building A Company Around an Idea

If you needed one word to describe the approach of PanTher Therapeutics Co-Founder and CEO Laura Indolfi it would be “proactive”.

Fresh off winning an Amgen Golden Ticket at LabCentral towards the end of 2018, Laura and her team of nearly 10 people between full-time employees and consultants, are taking full advantage of the access to innovative infrastructure made available to golden ticket winners at LabCentral.

Continue reading “Building A Company Around an Idea” »

January 30, 2019

Project OnRamp to Boost Diversity in Biotech and Tap New Talent With 50 Well-Paid Summer Positions For Students From Low-Income Backgrounds

Massachusetts Biotechnology Industry Creates First-In-Nation Program to Open Doors to Life Sciences Careers

FRAMINGHAM – January 29, 2019 –  The leading life sciences organizations in Massachusetts today announced the start of Project Onramp, a new program that matches talented, first-generation students from low-income backgrounds with well-paid summer internships. The internships are intended to serve as a stepping-stone to a rewarding career for a talent pool that has typically had difficulty gaining access to the burgeoning life science industry. It will also help growing Massachusetts biotechnology companies fill the additional 12,000 positions estimated to be created by 2023.

Continue reading “Project OnRamp to Boost Diversity in Biotech and Tap New Talent With 50 Well-Paid Summer Positions For Students From Low-Income Backgrounds” »

January 30, 2019

Progress continues on Berkshires life sciences innovation hub

State and local officials gather for topping off ceremony for 22,500 square-foot facility

Pittsfield, MA – January, 29, 2019 – officials with the Berkshire Innovation Center (BIC) and Pittsfield Mayor Linda Tyer joined state and other local officials at the BIC construction site for a topping off ceremony to recognize the significant progress made so far on construction of the 22,500 square-foot facility. The brief ceremony included the installation of the final steel beam in the infrastructure of the building. The beam was signed by key stakeholders and partners of the project.

Continue reading “Progress continues on Berkshires life sciences innovation hub” »

December 10, 2018

Catalyzing Success and Growth

Massachusetts, as the hub of the life sciences ecosystem, offers an abundance of opportunities and resources for early-stage life sciences companies. From state funding to the world’s leading innovation and talent pipelines, it’s no surprise that Massachusetts has become a breeding ground for early-stage companies to emerge and quickly grow toward commercial success.

Platelet Biogenesis (PBG) is a Cambridge-based company leading the production of functional human platelets from stem cells and developing platelet-based therapeutics. Platelets are the cells in the bloodstream that promote clot formation. They also demonstrate potential to be a crucial therapeutic for those exposed to radiation, which damages the body’s ability to produce platelets, and for many patients undergoing treatment for cancer, who also lose the ability to make platelets. Platelets have a short five-day shelf life, so they are almost always in limited supply.

Continue reading “Catalyzing Success and Growth” »

December 3, 2018

STAT+: Almost No venture capital funding goes to women. Can a pitchfest bring parity to biotech?

By Kate Sheridan 11/29/18

In many ways, the pitch night in Kendall Square on Wednesday was business as usual. Founders presented their young biopharma and medical device companies to investors, promising they could someday take away people’s pain, capture markets — even save lives. Read more…

November 28, 2018

Baker-Polito Administration Announces Sanofi as Newest Partner for Massachusetts Life Sciences Center Initiative for Women Entrepreneurs

Massachusetts Next Generation Initiative receives $250,000 from Sanofi; Announcement made during event to promote women entrepreneurs in the life sciences industry

CAMBRIDGE, MA – Today, the Baker-Polito Administration announced Sanofi as the newest funding partner for the Massachusetts Life Sciences Center’s (MLSC) Massachusetts Next Generation Initiative (MassNextGen), a competitive program for women-led life sciences companies. Sanofi will contribute $250,000 to the public-private partnership. Baker-Polito Administration and Sanofi officials made the announcement during the MLSC’s A Pitch of Their Own event, which promotes women entrepreneurs in the life sciences community.

Continue reading “Baker-Polito Administration Announces Sanofi as Newest Partner for Massachusetts Life Sciences Center Initiative for Women Entrepreneurs” »

November 13, 2018

A Massachusetts Life Sciences Culture

Extend Biosciences, Inc. is an emerging biotechnology company developing a novel drug delivery platform. It is aiming to crack the code on the therapeutic value of peptides and proteins utilizing proprietary platform technology with the potential to revolutionize drug delivery and provide patients a better quality of life.

Continue reading “A Massachusetts Life Sciences Culture” »

Connect With Us

Blog Facebook LinkedIn Twitter